Helicobacter pylori upregulates expression of epidermal growth factor- related peptides, but inhibits their proliferative effect in MKN 28 gastric mucosal cells

Journal of Clinical Investigation

Volumn 101, Issue 8, 1998, Pages 1604-1613

  Romano, Marco ^a,b   Ricci, Vittorio ^c   Di Popolo, Anna ^a   Sommi, Patrizia ^c   Del Vecchio Blanco, Camillo ^b   Bruni, Carmelo B ^a   Ventura, Ulderico ^c   Cover, Timothy L ^d   Blaser, Martin J ^d   Coffey, Robert J ^d   Zarrilli, Raffaele ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b II Ateneo di Napoli   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

Amphiregulin; EGF receptor; Gastric cell proliferation; Helicobacter pylori; Heparin binding EGF like growth factor

Indexed keywords

AMPHIREGULIN; EPIDERMAL GROWTH FACTOR;

ARTICLE; BINDING AFFINITY; CELL MIGRATION; CELL PROLIFERATION; GENE EXPRESSION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; STOMACH MUCOSA; WOUND HEALING;

EID: 0032522986     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI1174     Document Type: Article

References (61)

1. Blaser, M.J. 1992. Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology. 102:720-727.
2. NIH Consensus Development Panel. 1994. Helicobacter pylori in peptic ulcer disease. JAMA. 272:65-75.
3. Nomura, A., G.N. Stemmermann, P.-H. Chyou, I. Kato, G.I. Perez-Perez, and M.J. Blaser. 1991. Helicobacter pylori infection and gastric carcinoma in a population of Japanese Americans in Hawaii. N. Engl. J. Med. 325: 1132-1136.
4. Parsonnet, J., G.D. Friedman, D.P. Vandersteen, Y. Chang, J.H. Vogelman, N. Orentreich, and R.K. Sibley. 1991. Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 325:1127-1131.
5. Dunn, B.E. 1993. Pathogenic mechanisms of Helicobacter pylori. Gastroenterol. Clin. N. Am. 22:43-57.
6. Lee, A., J. Fox, and S. Hazell. 1993. Pathogenicity of Helicobacter pylori: a perspective. Infect. Immun. 61:1601-1610.
7. Cover, T.L., and M.J. Blaser. 1992. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J. Biol. Chem. 267:10570-10575.
8. Ghiara, P., M. Marchetti, M.J. Blaser, M.K.R. Tummuru, T.L. Cover, E.D. Segal, L.S. Tompkins, and R. Rappuoli. 1995. Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of disease. Infect. Immun. 63:4154-4160.
9. Telford, J.L., A. Covacci, P. Ghiara, C. Montecucco, and R. Rappuoli. 1994. Unravelling the pathogenic role of Helicobacter pylori in peptic ulcer: potential new therapies and vaccines. Trends Biotechnol. 12:420-426.
10. Covacci, A., S. Censini, M. Bugnoli, R. Petracca, D. Burroni, G. Macchia, A. Massone, E. Papini, Z. Xiang, N. Figura, and R. Rappuoli. 1993. Molecular characterization of the 128-kDa immunodominant antigen in Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc. Natl. Acad. Sci. USA. 90:5791-5795.
11. Tummuru, M.K.R., T.L. Cover, and M.J. Blaser. 1993. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect. Immun. 61:1799-1809.
12. Blaser, M.J., G.I. Perez-Perez, H. Kleanthous, T.L. Cover, R.M. Peek, P.-H. Chyou, G.N. Stemmermann, and A. Nomura. 1995. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 55:2111-2115.
13. Xiang, Z., S. Censini, P.F. Bayeli, J.L. Telford, N. Figura, R. Rappuoli, and A. Covacci. 1995. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major type and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect. Immun. 63:94-98.
14. Ricci, V., P. Sommi, R. Fiocca, E. Cova, N. Figura, M. Romano, K.J. Ivey, E. Solcia, and U. Ventura. 1993. Cytotoxicity of Helicobacter pylori on human gastric epithelial cells in vitro: role of cytotoxin(s) and ammonia. Eur. J. Gastroenterol. Hepatol. 5:687-694.
15. Ricci, V., C. Ciacci, R. Zarrilli, P. Sommi, M.K.R. Tummuru, C. Del Vecchio Blanco, C.B. Bruni, T.L. Cover, M.J. Blaser, and M. Romano. 1996. Effect of Helicobacter pylori on gastric epithelial cell migration and proliferation in vitro: role of VacA and CagA. Infect. Immun. 64:2829-2833.
16. Barnard, J.A., R.D. Beauchamp, W.E. Russell, R.N. Dubois, and R.J. Coffey. 1995. Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology. Gastroenterology. 108:564-580.
17. Romano, M., W.H. Polk, J.A. Awad, C.L. Arteaga, L.B. Nanney, M.J. Wargovich, E.R. Krause, C.R. Boland, and R.J. Coffey. 1992. Transforming growth factor α protection against drug-induced damage to the rat gastric mucosa in vivo. J. Clin. Invest. 90:2409-2421.
18. Konturek, S.J., T. Brzozowski, J. Majka, A. Dembinski, A. Slomiany, and B.L. Slomiany. 1992. Transforming growth factor alpha and epidermal growth factor in protection and healing of gastric mucosal injury. Scand. J. Gastroenterol. 27:649-655.
19. Chen, M.C., A.T. Lee, and A.H. Soll. 1991. Mitogenic response of canine fundic epithelial cells in short term culture to transforming growth factor α and insulin-like growth factor. J. Clin. Invest. 87:1716-1723.
20. Ciacci, C., R. Zarrilli, V. Ricci, A. De Luca, G. Mazzacca, C. Del Vecchio Blanco, and M. Romano. 1996. Histamine H2 receptor antagonists stimulate proliferation but not migration of human gastric mucosal cells in vitro. Dig. Dis. Sci. 41:972-978.
21. Dignass, A.U., and D.K. Podolski. 1993. Cytokine modulation of intestinal epithelial cell restitution: central role of transforming growth factor beta. Gastroenterology. 105:1323-1332.
22. Silen, W. 1987. Gastric mucosal defense and repair. In Physiology of the Gastrointestinal Tract. 2nd ed. L.R. Johnson, editor. Raven Press, New York. 1055-1069.
23. Polk, W.H., P.J. Dempsey, W.E. Russell, P.I. Brown, R.D. Beauchamp, J.A. Barnard, and R.J. Coffey. 1992. Increased production of transforming growth factor α following acute gastric injury. Gastroenterology. 102:1467-1474.
24. Romano, M., C.A. Lesch, K.S. Meise, M. Veljaca, B. Sanchez, E.R. Krause, C.R. Boland, A. Guglietta, and R.J. Coffey. 1996. Increased gastroduodenal concentrations of transforming growth factor α in adaptation to aspirin in monkeys and rats. Gastroenterology. 110:1446-1455.
25. Tarnawski, A., J. Stachura, T. Durbin, J.I. Sarfeh, and H. Gergely. 1992. Increased expression of epidermal growth factor receptor during gastric ulcer healing in rats. Gastroenterology. 102:695-698.
26. Playford, R.J., and N.A. Wright. 1996. Why is epidermal growth factor present in the gut lumen? Gut. 38:303-305.
27. Uribe, J.M., and K.E. Barrett. 1997. Nonmitogenic actions of growth factors: an integrated view of their role in intestinal physiology and pathophysiology. Gastroenterology. 112:255-268.
28. Hojo, H. 1977. Establishment of cultured lines of human stomach cancer. Origin and their morphological characteristics. Niigata Igakukai Zasshi. 91: 737-752.
29. Romano, M., M. Razandi, S. Sekhon, W.J. Krause, and K.J. Ivey. 1988. Human cell line for study of damage to gastric epithelial cells in vitro. J. Lab. Clin. Med. 111:430-440.
30. Ricci, V., R. Fiocca, P. Sommi, E. Cova, M. Romano, O. Luinetti, P. Barattini, K.J. Ivey, E. Solcia, and U. Ventura. 1992. MKN 28 cell line: a useful tool to study human gastric epithelial cells. Pflug. Arch. 420:R182. (Abstr.)
31. Cover, T.L., M.K.R. Tummuru, P. Cao, S.A. Thompson, and M.J. Blaser. 1994. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J. Biol. Chem. 269:10566-10573.
32. Tummuru, M.K.R., T.L. Cover, and M.J. Blaser 1994. Mutation of the cytotoxin-associated cagA gene does not affect the vacuolating cytotoxin activity of Helicobacter pylori. Infect. Immun. 62:2609-2613.
33. Tummuru, M.K.R., S. Sharma, and M.J. Blaser 1995. Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol. Microbiol. 18:867-876.
34. Cover, T.L., Y. Glupczynski, A.P. Lage, A. Burette, M.K.R. Tummuru, G.I. Perez-Perez, and M.J. Blaser. 1995. Serologic detection of infection with cagA+ Helicobacter pylori strains. J. Clin. Microbiol. 33:1496-1500.
35. Chomczinski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
36. Zarrilli, R., S. Pignata, M. Romano, A. Gravina, S. Casola, C.B. Bruni, and A.M. Acquaviva. 1994. Expression of insulin-like growth factor II (IGF-II) and IGF-I receptor during proliferation and differentiation of CaCo-2 human colon carcinoma cells. Cell Growth Differ. 5:1085-1091.
37. Derynck, R., A.B. Roberts, M.E. Winkler, E.Y. Chen, and D.V. Goeddel. 1984. Human transforming growth factor-α: precursor structure and expression in E. coli. Cell. 38:287-297.
38. Higashiyama, S., J.A. Abraham, J. Miller, J.C. Fiddes, and M. Klagsburn. 1991. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science.251:936-939.
39. Shoyab, M., G.D. Plowman, V.L. McDonald, J.F. Bradley, and G.J. Todaro. 1988. Amphiregulin: a bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocarcinoma cell lile MCF7. Proc. Natl. Acad. Sci. USA. 85:6528-6532.
40. Tso, J. Y., X.H. Sun, T. Kao, S. Reece, and R. Wu. 1985. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNA: genomic complexity and molecular evolution of the gene. Nucleic Acids Res. 13:2485-2502.
41. Auricchio, F., M. Di Domenico, A. Migliaccio, G. Castoria, and A. Bilancio. 1995. The role of estradiol receptor in the proliferative activity of vanadate in MCF-7 cells. Cell Growth Differ. 6:105-113.
42. Dluz, S.M., S. Higashiyama, D. Damm, J.A. Abraham, and M. Klagsbrun. 1993. Heparin-binding epidermal growth factor-like growth factor expression in cultured fetal human vascular smooth muscle cells. J. Biol. Chem. 268: 18330-18334.
43. Zarrilli, R., M. Romano, S. Pignata, S. Casola, C.B. Bruni, and A.M. Acquaviva. 1996. Constitutive IGF-II expression interferes with the enterocyte-like differentiation of CaCo-2 cells. J. Biol. Chem. 271:8108-8114.
44. McPerson, G.A. 1985. Analysis of radioligand binding experiments: a collection of computer programs for the IBM PC. J. Pharmacol. Methods. 14: 213-228.
45. Hashimoto, K., S. Higashiyama, H. Asada, E. Hashimura, T. Kobayashi, K. Sudo, T. Nagakawa, D. Damm, K. Yoshikawa, and N. Taniguchi. 1994. Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes. J. Biol. Chem. 269:20060-20066.
46. 2-terminal region is not critical for bioactivity. J. Biol. Chem. 268:18835-18843.
47. Censini, S., C. Lange, Z. Xiang, J.R. Crabtree, P. Ghiara, M. Borodovski, R. Rappuoli, and A. Covacci. 1996. cag, a pathogenicity island of Helicobacter pylori, encodes type-I specific and disease-associated virulence factors. Proc. Natl. Acad. Sci. USA. 93:14648-14653.
48. Tarnawski, A., K. Tanque, A.M. Santos, and I.J. Sarfeh. 1995. Cellular and molecular mechanisms of peptic ulcer healing. Is the quality of mucosal scar affected by treatment? Scand. J. Gastroenterol. 30 210(Suppl.):9-14.
49. Konturek, P.C., T. Brzozowski, S.J. Konturek, H. Ernst, D. Drozdowicz, R. Pajdo, and E.G. Hahn. 1997. Expression of epidermal growth factor and transforming growth factor alpha during ulcer healing. Scand. J. Gastroenterol. 32:6-15.
50. Murayama, Y., J.-I. Miyagawa, S. Hiashiyama, S. Kondo, M. Yabu, K. Isozaki, Y. Kayanoki, S. Kanayama, Y. Shinomura, N. Taniguchi, and Y. Matsuzawa. 1995. Localization of heparin-binding epidermal growth factor-like growth factor in human gastric mucosa. Gastroenterology. 109:1051-1059.
51. Tsutsui, S., Y. Shinomura, Y. Higashimoto, S. Kanayama, Y. Miyazaki, T. Minami, Y. Murayama, S. Kitamura, S. Hiraoka, J. Miyagawa, et al. 1996. Induction of heparin-binding epidermal growth factor-like growth factor mRNA expression after acute gastric injury in rats. Gastroenterology. 110:1128 (Abstr.)
52. Homma, T., M. Sakai, H.F. Cheng, T. Yasuda, R.J. Coffey, Jr., and R.C. Harris. 1995. Induction of heparin-binding epidermal growth factor-like growth factor mRNA in rat kidney after acute injury. J. Clin. Invest. 96:1018-1025.
53. Lynch, D.A.F., N.P. Mapstone, A.M.T. Clarke, G.M. Sobala, P. Jackson, L. Morrison, M.F. Dixon, P. Quirke, and A.T.R. Axon. 1995. Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy. Gut. 36:346-350.
54. Correa, P., and Y.-H. Shiao. 1994. Phenotypic and genotypic events in gastric carcinogenesis. Cancer Res. 54:1941s-1943s.
55. Naef, M., M. Yokoyama, H. Friess, M.W. Buchler, and M. Korc. 1996. Heparin-binding EGF-like growth factor is over-expressed in human gastric carcinoma. Gastroenterology. 110:565 (Abstr.)
56. Cook, P., M.R. Pittelkow, W.W. Keeble, R. Graves-Deal, R.J. Coffey, Jr., and G.D. Shipley. 1992. Amphiregulin messenger RNA is elevated in psoriatic epidermis and gastrointestinal carcinomas. Cancer Res. 523224-3227.
57. Lesch, C.A., and A. Guglietta. 1995. PD153035, an EGF receptor (EGFr) tyrosine-kinase specific inhibitor, reverses the effect of EGF on gastric secretion and TNBS-induced colitis in rats. Gastroenterology. 108:735. (Abstr.)
58. Rutten, M.J., P.J. Dempsey, C.A. Luttropp, M.A. Hawkey, B.C. Sheppard, R.A. Crass, C.W. Deveney, and R.J. Coffey. 1996. Identification of an EGF/TGF-α receptor in primary cultures of guinea pig gastric mucous epithelial cells. Am. J. Physiol. 270:G604-G612.
59. Aaronson, S.A. 1991. Growth factors and cancer. Science. 254:1146-1153.
60. Riese, D.J., E.D. Kim, K. Elenius, S. Buckley, M. Klagsbrun, G.D. Plowman, and D.F. Stern. 1996. The epidermal growth factor receptor couples transforming growth faclor-α, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErhB-4. J. Biol. Chem. 271: 20047-20052.
61. Coso, O.A., M. Chiariello, J.-C. Yu, H. Teramoto, P. Crespo, N. Xu, T. Miki, and J.S. Gutkind. 1995. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signalling pathway. Cell. 81:1137-1146.